Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen-Reference-Cited by-同舟云学术

Results of a Phase II Multicenter Trial of Pentostatin and Rituximab in Patients with Low-Grade B-Cell Non-Hodgkin's Lymphoma: An Effective and Minimally Toxic Regimen

Published:2003-12 Issue:3 Volume:4 Page:169-175
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Drapkin Robert,Di Bella Nicholas J.,Faragher David C.,Harden Elizabeth,Matei Carmen,Hyman William,Mirabel Mae,Boehm Kristi A.,Asmar Lina

Publisher

Elsevier BV

Subject

Cancer Research

Reference33 articles.

1. Lymphomas;Foon,1995

2. Fludarabine in untreated and previously treated B-CLL patients: a report on efficacy and toxicity;Spriano;Haematologica,1994

3. Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes;Helman;Chest,2002

4. Pentostatin (2′-deoxycoformycin, dCF) in patients with low-grade (B-T-cell) and intermediate- and high-grade (T-cell) malignant lymphomas: phase II study of the EORTC Early Clinical Trials Group;Monfardini;Oncology,1996

5. 2′ Deoxycoformycin (pentostatin) for refractory non-Hodgkin's lymphoma: a CALGB phase II study;Duggan;Med Pediatr Oncol,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies;The AAPS Journal;2017-02-21

2. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy;Journal of Renal Injury Prevention;2016-11-02

3. Rituximab (Rituxan®);Handbook of Therapeutic Antibodies;2014-08-12

4. Monoclonal antibody therapy;Principles of Cancer Biotherapy;2009

5. Pulmonary Complications of Novel Antineoplastic Agents for Hematologic Malignancies;Clinical Pulmonary Medicine;2008-03